GelStat Corp. (OTCMKTS:GSAC) Short Interest Down 14.3% in October

GelStat Corp. (OTCMKTS:GSAC) was the recipient of a large decline in short interest in the month of October. As of October 15th, there was short interest totalling 62,100 shares, a decline of 14.3% from the September 30th total of 72,500 shares. Based on an average trading volume of 8,851,200 shares, the short-interest ratio is currently 0.0 days.

GelStat Stock Performance

GSAC remained flat at $0.00 during trading on Thursday. GelStat has a fifty-two week low of $0.00 and a fifty-two week high of $0.00.

About GelStat

GelStat Corporation, a consumer health care company, engages in the research, development, and marketing of over-the-counter and other non-prescription consumer health care products. Its products include GelStat Migraine, a patented solution used for pain relief from migraine headaches; Chews 2 Lose, an appetite suppressant gum for diet aide; All Natural Speed, an energy supplement product; and GelStat Sleep, a product for relief from sleep disorders and its associated symptoms.